We will update this article following the July advisory vote
Those are weeks you do not get back
Therefore, preliminary in vitro validation is required to confirm feasibility
Again, I'm not here to tell you what to do or what not to do, but if you have it in mind that peptide therapeutics, because they aren't hormone therapies, are not without their potential risks, you would be wrong
What we tell our patients: If you are considering peptide therapy, speak with a licensed clinician who can assess your specific health situation, explain the current regulatory status accurately, and if a peptide protocol is appropriate ensure it is obtained through a verifiable, quality-controlled pharmacy
Insulin Syringes (U100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes (recommend 1 100count box) 12 weeks: 84 syringes (1 100count box) Preferred: 0.30.5 mL size with 28G31G needle, 5/16 to 1/2 length for subcutaneous use